Open AccessPharmacological Wnt ligand inhibition overcomes key tumor-mediated resistance pathways to anti-PD-1 immunotherapy
Author(s) -
Nicholas C. DeVito,
Michael Sturdivant,
Balamayooran Thievanthiran,
Christine Xiao,
Michael P. Plebanek,
April K.S. Salama,
Georgia M. Beasley,
Alisha Holtzhausen,
Veronica NovotnyDiermayr,
John H. Strickler,
Brent A. Hanks
Publication year - 2021
Publication title -
cell reports
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 6.264
H-Index - 154
eISSN - 2639-1856
pISSN - 2211-1247
DOI - 10.1016/j.celrep.2021.109071
Subject(s) - wnt signaling pathway , autocrine signalling , cancer research , immunotherapy , paracrine signalling , tumor microenvironment , immune checkpoint , blockade , immune system , biology , cancer immunotherapy , signal transduction , immunology , microbiology and biotechnology , receptor , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom